Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

993
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
993
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

883
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
883
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

487
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
487
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

726
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
726

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PlantCircRNA: a comprehensive database for plant circular RNAs.

Nucleic acids research·2024
Same author

SplicingTypesAnno: annotating and quantifying alternative splicing events for RNA-Seq data.

Computer methods and programs in biomedicine·2015
Same author

Digital inventory of Arabidopsis transcripts revealed by 61 RNA sequencing samples.

Plant physiology·2014
Same journal

Perceived Self-Efficacy and Its Determinants for Noncommunicable Disease Prevention Among Adults in Southern Ethiopia: A Community-Based Cross-Sectional Study.

BioMed research international·2026
Same journal

Resveratrol Mitigates Noise-Induced Cochlear Damage and Delays Hearing Loss in Wistar Rats.

BioMed research international·2026
Same journal

RETRACTION: Green Fabrication of Silver Nanoparticles Using Euphorbia Serpens Kunth Aqueous Extract, their Characterization, and Investigation of its in Vitro Antioxidative, Antimicrobial, Insecticidal, and Cytotoxic Activities.

BioMed research international·2026
Same journal

Predictors of Prolonged Hospital Length of Stay in Patients With Odontogenic Infections in Ghana.

BioMed research international·2026
Same journal

Traditional Chinese Medicine Bone-Setting Techniques Research Progress for the Treatment of Knee Osteoarthritis.

BioMed research international·2026
Same journal

RETRACTION: miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1.

BioMed research international·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K

Exploring population pharmacokinetic modeling with resampling visualization.

Fenghua Zuo1, Jun Li2, Xiaoyong Sun3

  • 1College of Information Engineering, Taishan Medical University, Taian, Shandong 271016, China.

Biomed Research International
|May 31, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces a new graphical diagnostic approach for population pharmacokinetic (PopPK) models. It effectively identifies influential outliers in drug development by visualizing resampling statistics, enhancing model validation.

More Related Videos

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.4K
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.6K

Related Experiment Videos

Last Updated: Apr 28, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.4K
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.6K

Area of Science:

  • Pharmacokinetics
  • Drug Development
  • Statistical Modeling

Background:

  • Population pharmacokinetic (PopPK) modeling is crucial in drug research and development for dose-concentration relationships.
  • PopPK models offer flexibility with sparse and unbalanced data.
  • Resampling methods are vital for PopPK model validation and assessing parameter uncertainty.

Purpose of the Study:

  • To present a novel graphical diagnostic approach for population pharmacokinetic (PopPK) models.
  • To visualize resampling statistics for enhanced PopPK model analysis.
  • To identify influential outliers in PopPK modeling.

Main Methods:

  • Adapted multivariate analysis techniques, including parallel coordinate plots and multidimensional scaling.
  • Visualized resampling statistics such as case deletion and bootstrap.
  • Integrated static and interactive graphics for multidimensional data exploration.

Main Results:

  • Developed a graphical method to visualize PopPK model diagnostics.
  • Demonstrated the approach's capacity to identify statistically influential outliers.
  • Revealed dependencies between different resampling statistics through careful scaling.

Conclusions:

  • The proposed graphical method offers a complementary approach to existing PopPK analysis techniques.
  • Combines static and interactive graphics for a systematic exploration of multidimensional data.
  • Provides a new perspective for PopPK modeling analysis in drug development.